~静
Lv45
680 积分
2023-02-28 加入
-
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
1天前
已完结
-
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
3天前
已关闭
-
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
3天前
已完结
-
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
3天前
已完结
-
HER2-targeted therapies — a role beyond breast cancer
3天前
已完结
-
Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond
3天前
已完结
-
The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
3天前
已完结
-
Novel development strategies and challenges for anti-Her2 antibody-drug conjugates
3天前
已完结
-
Targeting HER2 expression in cancer: New drugs and new indications
3天前
已完结
-
Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer
25天前
已完结